Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Citi Cuts BP And JPMorgan Downgrades Shell

Thu, 12th Mar 2020 09:25

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

CITIGROUP CUTS BP TO 'NEUTRAL' (BUY) - PRICE TARGET 340 (640) PENCE

----------

JPMORGAN CUTS BP PRICE TARGET TO 475 (600) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS ROYAL DUTCH SHELL B TO 'NEUTRAL' (OVERWEIGHT) - PRICE TARGET 1750 (2850) PENCE

----------

CITIGROUP CUTS ROYAL DUTCH SHELL PRICE TARGET TO 1320 (2040) PENCE - 'SELL'

----------

CREDIT SUISSE CUTS ROYAL DUTCH SHELL PRICE TARGET TO 2050 (2750) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES OCADO PRICE TARGET TO 1700 (1600) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES BURBERRY TO 'MARKET-PERFORM' ('UNDERPERFORM') - TARGET 1800 PENCE

----------

DEUTSCHE BANK CUTS BURBERRY PRICE TARGET TO 1950 (1990) PENCE - 'HOLD'

----------

BERENBERG CUTS INFORMA PRICE TARGET TO 635 (845) PENCE - 'HOLD'

----------

JEFFERIES RAISES HIKMA PHARMACEUTICAL PRICE TARGET TO 2390 (2300) PENCE - 'BUY'

----------

BOFA RAISES FERGUSON TO 'NEUTRAL' ('UNDERPERFORM')

----------

BOFA RAISES VODAFONE PRICE TARGET TO 238 (236) PENCE - 'BUY'

----------

FTSE 250

----------

NUMIS RAISES SPIRENT TO 'BUY'

----------

LIBERUM CUTS NETWORK INTERNATIONAL TARGET TO 635 (680) PENCE - 'BUY'

----------

LIBERUM CUTS EQUINITI PRICE TARGET TO 275 (290) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS WEIR GROUP PRICE TARGET TO 1300 (1500) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS ROTORK PRICE TARGET TO 280 (315) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS IMI PRICE TARGET TO 1140 (1230) PENCE - 'BUY'

----------

RBC CUTS HUNTING PRICE TARGET TO 290 (630) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS INTEGRAFIN PRICE TARGET TO 470 (490) PENCE - 'BUY'

----------

JEFFERIES RAISES BALFOUR BEATTY PRICE TARGET TO 265 (260) PENCE - 'HOLD'

----------

RBC CUTS PROVIDENT FINANCIAL PRICE TARGET TO 420 (445) PENCE - 'SECTOR PERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

BOFA CUTS FEVERTREE DRINKS TO 'NEUTRAL'

----------

BARCLAYS RAISES BREEDON PRICE TARGET TO 94 (92) PENCE - 'EQUAL WEIGHT'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.